Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Starkel, Peter" or (type any "bookEditor issueEditor" and editor="Starkel, Peter")

Add to list
- Journal Article
- open access
Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital

Sylvie Goletti, Siméon Zuyten, Léonie Goeminne, Chris Verhofstede, Hector Rodriguez-Villalobos, Monique Bodeus, Peter Stärkel, Yves Horsmans and Benoît Kabamba-Mukadi

(2019) BMC Infectious Diseases.
Add to list
- Conference Paper
- C3
Multicenter Belgian experience of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: safety and efficacy results

Delphine Degré, Wim Laleman, Xavier Verhelst (UGent) , Anne Lamproye, Thomas Vanwolleghem, Thierry Gustot, Peter Starkel, Nicolas Lanthier, Peter Michielsen, Jean Delwaide, et al.

(2015) ACTA GASTRO-ENTEROLOGICA BELGICA. 78(1).
Add to list
- Conference Paper
- C3
Multicenter Belgian experience of sofosbuvir medical need program in pre- and post liver transplantation patients : safety and efficacy results

Delphine Degre, Wim Laleman, Xavier Verhelst (UGent) , Anne Lamproye, Thomas Vanwolleghem, Thierry Gustot, Peter Starkel, Nicolas Lanthier, Peter Michielsen, Jean Delwaide, et al.

(2015) TRANSPLANT INTERNATIONAL. 28(suppl. 4). p.21-21
Add to list
IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use ?

Hans Orlent, Hendrik Reynaert, Stefan Bourgeois, Vinciane Dideberg, Michael Adler, Isabelle Colle (UGent) , Stephane De Maeght, Wim Laleman, Peter Michielsen, Christophe Moreno, et al.

(2011) ACTA GASTRO-ENTEROLOGICA BELGICA. 74(2). p.317-322
Add to list
- Journal Article
- A1
- open access
Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma

Femke Heindryckx (UGent) , Koen Mertens (UGent) , Nicolas Charette, Bert Vandeghinste (UGent) , Christophe Casteleyn (UGent) , Christophe Van Steenkiste (UGent) , Dominique Slaets (UGent) , Louis Libbrecht (UGent) , Steven Staelens (UGent) , Peter Starkel, et al.

(2010) MOLECULAR CANCER. 9.
Add to list
- Journal Article
- A1
- open access
Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat

Meng Fang (UGent) , Sylviane Dewaele (UGent) , Yun-peng Zhao, Peter Starkel, Valerie Vanhooren (UGent) , Yue-ming Chen, Xin Ji, Ming Luo, Bao-mu Sun, Yves Horsmans, et al.

(2010) MOLECULAR CANCER. 9.
Add to list
Angiogenic changes in a new mouse model for hepatocellular carcinoma assessed with state-of-the-art imaging technology

Femke Heindryckx (UGent) , Bert Vandeghinste (UGent) , Christophe Casteleyn (UGent) , Nicolas Charette, Dominique Slaets (UGent) , Louis Libbrecht (UGent) , Steven Staelens (UGent) , Peter Stärkel, Anja Geerts (UGent) , Isabelle Colle (UGent) , et al.

(2010) JOURNAL OF HEPATOLOGY. 52(suppl. 1). p.S340-S340
Add to list
Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the eurotransplant allocation system

Michael Adler, Filip De Pauw, Pierre Vereerstraeten, Agnese Fancello, Jan Lerut, Peter Starkel, Hans Van Vlierberghe (UGent) , Roberto Troisi (UGent) , Vincent Donckier, Olivier Detry, et al.

(2008) LIVER TRANSPLANTATION. 14(4). p.526-533

Academic Bibliography

Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital

Multicenter Belgian experience of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: safety and efficacy results

Multicenter Belgian experience of sofosbuvir medical need program in pre- and post liver transplantation patients : safety and efficacy results

IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use ?

Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma

Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat

Angiogenic changes in a new mouse model for hepatocellular carcinoma assessed with state-of-the-art imaging technology

Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the eurotransplant allocation system

Contents

Support

Contact